Business
Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program
(TheNewswire) Toronto, Ontario – TheNewswire - August 18, 2025 – ...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Toronto, Ontario –\n \n\n TheNewswire -\n \n\n August 18, 2025\n \n\n –\nVentripoint Diagnostics Ltd.\n \n\n (“\n \n\n Ventripoint\n \n\n ” or the\n“\n \n\n Corporation\n \n\n ”,\n \n\n )\n \n\n (\n \n\n TSXV:VPT; OTC:VPTDF)\n \n\n a leader in AI-powered heart analysis solutions, is pleased\nto announce the appointment of\n \n\n Thomas Brown\n \n\n , former Vice President of North\nAmerican Sales at Intelligent Ultrasound, as\n \n\n Director of the Congenital Heart Defect\n(CHD) Program\n \n\n .\n \n\n\n\n Mr. Brown brings more than 20 years of leadership\nexperience in global medical imaging sales, commercialization, and\nmarket expansion. At Intelligent Ultrasound, he drove significant\ninternational growth, launching AI-powered imaging solutions into both\nclinical and training markets.\n \n\n\n\n This appointment is a strategic move to accelerate\nVentripoint’s market leadership in the congenital heart defect\nsegment - one of the largest and fastest-growing areas in pediatric\ncardiology - with the potential to expand adoption of VMS+™ into\nrelated high-value markets such as cardio-oncology, pulmonary\nhypertension, heart failure, and valve disease.\n \n\n\n\n “Thomas’s expertise in scaling innovative imaging\nsolutions will be a catalyst for growth in our CHD program and\nbeyond,” said Hugh MacNaught, President & CEO of Ventripoint\nDiagnostics. “This is a key step in executing our multi-segment\ngrowth strategy.”\n \n\n\n\n Ventripoint’s VMS+™ technology enables accurate,\nMRI-comparable cardiac volumetric analysis using standard 2D cardiac\nultrasound - dramatically reducing costs, eliminating wait times, and\nexpanding access for clinicians and patients.\n \n\n\n\n Mr. Brown’s career spans over 20 years in healthcare\ntechnology sales and market development, with a focus on introducing\ninnovative imaging solutions into clinical practice. At Intelligent\nUltrasound, he was responsible for significant revenue growth,\ninternational market expansion, and the launch of cutting-edge AI\nproducts into the healthcare...